Remove Article Remove Management Remove Manufacturing Remove Provider
article thumbnail

Researchers Propose Solutions to Improve GLP-1 RA Access

Physician's Weekly

Other Persistent Barriers & Potential Solutions In another article not presented at the meeting, Stephanie W. Seventeen states include anti-obesity medications under Medicaid, which provides healthcare for people with low incomes, but only nine of these have preferred drug plans that cover the newer agents.”

article thumbnail

A Chihuahua or a Muffin? FDA Announces Plans for Aggressive Use of Artificial Intelligence

FDA Law

Another article about CLAT (available here ) suggests FDAs model will continually learn and improve over time. As we recently blogged about here and here , FDA has issued guidance on lifecycle management for AI-enabled device software functions. We have all seen AI failures online, some amusing (e.g.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Draft Guidance Provides Detailed (and Burdensome) Recommendations for Chemical Assessments to Support Medical Device Biocompatibility

FDA Law

Chemical characterization can also be useful in evaluating a change to the materials or manufacturing of a device. The draft guidance provides recommendations for collection and reporting of chemical characterization data and discusses the topics of information gathering, test article extraction, chemical analysis, and data reporting.

article thumbnail

Quiet on the Set? Forbidding FDA To Take Photographs During An Inspection Can Be Regrettable

FDA Law

The current Warning Letter was issued to a drug manufacturer in China (Tianjin Darentang Jingwanhong Pharmaceutical Co., Management, according to the Warning Letter, “stated that the investigators were not allowed to take photographs of the equipment as part of the inspection.”

article thumbnail

ACI’s 12th Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care

FDA Law

The conference is the premier event on cosmetics and personal care products, where industry leaders will provide essential updates on compliance with Modernization of Cosmetics Regulation Act of 2022 (MoCRA), state legislative reforms, and new FTC advertising guidelines.

article thumbnail

Ep. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. Adler, J.D., of Roetzel & Andress

Physician's Practice

Conclusion and Closing Remarks (00:25:02)** Thanking the guest, closing the episode, and providing subscription information. **Conclusion and Closing Remarks (00:25:02)** Thanking the guest, closing the episode, and providing subscription information. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. Adler, J.D., Singer, M.D.

article thumbnail

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

GeriPal

I could go on and on, but listen to the podcast instead and for a deeper dive, take a look at the following articles and studies: Gabapentin in the Perioperative setting: Prolonged use of newly prescribed gabapentin after surgery. 2022 Perioperative Gabapentin Use in Older AdultsRevisiting Multimodal Pain Management JAMA IM.